FDA approves Xenpozyme (olipudase alfa) to treat acid sphingomyelinase deficiency | Carrick Pharmacy
(Carrick Pharmacy News) The US Food and Drug Administration (FDA) has approved the first treatment for a rare genetic disease. Before this approval, no medication was approved to treat acid sphingomyelinase deficiency (ASMD). But now, the FDA has approved a drug called Xenpozyme (olipudase alfa) to treat this serious condition. ASMD can cause early death, …